EZH2 and acute kidney injury: Our previously study demonstrated that EZH2-mediated inflammation contributes to AKI, and that inhibiting EZH2 with ZLD1039 in renal tubular cells effectively mitigates renal inflammation and ameliorates kidney injury [20].